MedTrace Logo

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

NCT00097357 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 1238

Last updated 2010-03-02

No results posted yet for this study

Summary

The purpose of this study is to learn if BMS-562247 can prevent blood clots in the legs and lungs in men and women following unilateral total knee replacement surgery. The safety of this treatment will also be studied.

Conditions

Interventions

DRUG

Apixaban

Tablets, Oral, 12 +/- 2 days

DRUG

Enoxaparin

Injection, SQ, Q12H, 12 +/- 2 days

DRUG

Warfarin

Tablets, Oral, QD, 12 +/- 2 days

DRUG

Enoxaparin Placebo

Injection, SQ, BID, 12 +/- 2 days

DRUG

Apixaban Placebo

Tablets, Oral, BID, 12 +/- 2 days

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2005-12-31
Completion
2005-12-31

Countries

  • United States
  • Argentina
  • Australia
  • Canada
  • Denmark
  • Israel
  • Mexico
  • Poland
  • Puerto Rico

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00097357 on ClinicalTrials.gov